Left Ventricular Assist Device Percutaneous Deactivation With a Watchman Device

Myocardial recovery in patients with left ventricular assist devices is a rare event. Surgical explantation remains a risky and challenging procedure. Alternative percutaneous techniques could represent an effective solution. This report describes the clinical use of a Watchman closure device (Boston Scientific Corp, Marlborough, MA) in deactivation of a HeartMate 3 left ventricular assist device (Abbott Laboratories, Abbott Park, IL). (C) 2021 by The Society of Thoracic Surgeons

Automated summary

Myocardial recovery in LVAD patients is rare, and surgical explantation is risky. This report highlights the use of a Watchman closure device for deactivation of a HeartMate 3 LVAD.